
Louise Barber
@ljbarber2
Cancer genomics scientist @QMBCI; Proud wife&mum (alter ego @louzolfi)
ID: 1173517103258906624
16-09-2019 08:41:11
39 Tweet
26 Takipçi
52 Takip Edilen

The story of the Royal london hospital Team ACCU, the local community and Covid-19 told by the brilliant Clive Myrie and team @sampiranty starting tonight @RoyalLondonHosp Barts Health Martin P Griffiths 💙 🇯🇲🇬🇧



#COVID19 in the East end and @RoyalLondonHosp captured by Clive Myrie and team @sampiranty David McIlveen Team ACCU Barts Health Faruq BBC News (UK)



Our paper “Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer” is out in Nature Ecology and Evolution (nature.com/articles/s4155…). Thanks to Marco Gerlinger and team at The ICR & The Royal Marsden NHS Foundation Trust, Nuria Lopez-Bigas, Oriol Pich. Tweetorial:

Our lab works on multiple aspects of gastrointestinal cancers! We work with patients on active clinical trials who very kindly donate samples so we can create patient organoids - essentially regrow the patient's tumour in a plate suspended in a 3D matrigel.Marco Gerlinger


Honoured to be joining the Team ACCU Barts Charity London Landmarks Half Marathon team for my first ever half marathon run! The money raised makes such an immense difference to the patients and staff.




collaborators St Bartholomew's Hospital GI Cancer Centre, Michal Bassani-Sternberg, Sine Reker Hadrup, Naureen Starling, George Kassiotis and James Kinross to target T cells (red) to colorectal cancer cells (green) with surgical precision. Watch this space for Post-Doc opportunities.

We have an exciting Science and Innovation at Cancer Research UK funded PhD studentship studying Acetyl-CoA metabolism in Small Cell Lung Cancer, hosted Barts Cancer Institute (Queen Mary) supported by a stellar group of collaborators. If you want to do a translational PhD in metabolism, this is the one for you findaphd.com/phds/project/u…



ctDNA MRD detection is incredibly powerful in early-stage OG adenocarcinoma based on our ICONIC Ph2 trial (periop FLOT+PDL1) presented today at #AACR2023. Better than nodal status and TRG in multivariate. Can‘t wait to use in more trials and the clinic. Barts Cancer Inst. The Royal Marsden NHS Foundation Trust



Join the discussion: Pervasive Cellular Plasticity intertwined with Darwinian Evolution in Cancer - does this need a new Evolutionary Theory? See our review just out in Trends in Cancer sciencedirect.com/science/articl…
